Related Experiment Videos

[Mycobacterium genavense infection in 2 HIV seropositive patients in Amsterdam]

E J Kuijper1, M de Witte, D W Verhagen

  • 1Universiteit van Amsterdam, Academisch Medisch Centrum, Amsterdam.

Insights

Disseminated Mycobacterium genavense infection affects HIV-I patients with low CD4+ T lymphocytes. Antimycobacterial treatment proved effective for these disseminated mycobacterial infections.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Microbiology

Background:

  • Mycobacterium genavense is recognized as a cause of disseminated infections in HIV-seropositive individuals with compromised cellular immunity.
  • The clinical presentation of M. genavense infection often mimics generalized Mycobacterium avium-intracellulare infection.

Observation:

  • Two patients with Human Immunodeficiency Virus type 1 (HIV-I) infection presented with disseminated Mycobacterium genavense infection.
  • Symptoms included confusion, aphasia, diarrhea, dysphagia, and non-productive cough in a 47-year-old and a 32-year-old male, respectively.
  • Both patients exhibited low CD4+ T lymphocyte counts, indicating severe immune deficiency.

Findings:

  • Both patients responded positively to antimycobacterial treatment.
  • M. genavense is a slow-growing mycobacterium identifiable through enriched media and molecular techniques.
  • The infection is presumed to originate in the gastrointestinal tract via oral contamination.

Implications:

  • Early recognition and treatment of M. genavense are crucial for managing disseminated infections in immunocompromised patients.
  • Understanding the pathogenesis and diagnostic methods for M. genavense can improve patient outcomes.
  • Further research into M. genavense prevalence and transmission routes is warranted, especially in at-risk populations.

Related Concept Videos